-
4D Molecular Therapeutics (NASDAQ:FDMT) Earns Underweight Rating from Analysts at Morgan Stanley
Source: Buzz FX / 21 Nov 2024 06:51:09 America/Chicago
4D Molecular Therapeutics (NASDAQ:FDMT) Earns Underweight Rating from Analysts at Morgan Stanley Written by MarketBeat November 21, 2024 Share Link copied to clipboard. Research analysts at Morgan Stanley began coverage on shares of 4D Mole
Read more...